DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

JMP Securities Maintains Outperform on Cue Biopharma, Raises Price Target to $30

JMP Securities maintains Cue Biopharma (NASDAQ:CUE) with a Outperform and raises the price target from $22 to $30.

Benzinga · 03/06/2020 16:29

JMP Securities maintains Cue Biopharma (NASDAQ:CUE) with a Outperform and raises the price target from $22 to $30.